platinum has been researched along with Colonic Neoplasms in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (22.22) | 18.2507 |
| 2000's | 3 (8.33) | 29.6817 |
| 2010's | 20 (55.56) | 24.3611 |
| 2020's | 5 (13.89) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Chen, H; Guo, Z; Song, D; Wang, X; Wang, Y; Yang, T; Yuan, H; Zhang, S | 1 |
| Barbato, F; Gabano, E; Gariboldi, MB; Marras, E; Ravera, M | 1 |
| Cai, J; Cao, G; Hu, W; Huang, X; Huang, Y; Jiang, G; Liu, Z; Su, K; Wang, H; Wang, M; Wu, C; Yu, C | 1 |
| Baran, J; Depciuch, J; Klebowski, B; Parlinska-Wojtan, M; Stec, M | 1 |
| Bouvet, M; Clary, B; Han, Q; Higuchi, T; Hoffman, RM; Park, JH; Singh, SR; Sugisawa, N; Tan, Y; Yamamoto, J; Yoon, SN; Zhao, M | 1 |
| Arena, S; Bardelli, A; Mauri, G; Sartore-Bianchi, A; Siena, S | 1 |
| Baran, J; Depciuch, J; Klebowski, B; Komenda, W; Krzempek, D; Parlinska-Wojtan, M; Stec, M | 1 |
| Akerfeldt, MC; Hambley, TW; New, EJ; Shen, C; Tran, CM | 1 |
| Chi, Q; Wang, M; Yang, C; Zhou, J | 1 |
| Jon, S; Kim, HS; Kim, JY; Lee, DY; Lee, S; Lee, Y; Miao, W; Min, JJ | 1 |
| Keppler, BK; Koellensperger, G; Legin, A; Theiner, S; Van Acker, T; Van Malderen, SJM; Vanhaecke, F | 1 |
| Chen, F; Gou, S; Jin, X; Zhao, J | 1 |
| Alper, P; Aygun, M; Cevatemre, B; Icsel, C; Ulukaya, E; Yilmaz, VT | 1 |
| Briaitbard, O; Gammal, A; Ganot, N; Hochman, J; Tam, J; Tshuva, EY | 1 |
| Chang, Y; Cheng, Z; Deng, X; Liang, S; Lin, J; Ma, P; Shao, S; Sun, C; Xiao, X; Xie, Z; Zhang, H | 1 |
| An, X; Feng, Y; Hao, D; He, Y; Jin, X; Li, X; Li, Y; Li, Z; Ma, J; Meng, H; Tang, J; Wang, G; Wang, T; Wang, X; Weng, M; Wu, D; Yang, C; Yang, S; Yang, W; Zhang, L; Zheng, T; Zhu, Y | 1 |
| Blank, H; Gehrke, H; Gerthsen, D; Jarolim, K; Marko, D; Schneider, R | 1 |
| Berger, W; Galanski, MS; Göschl, S; Heffeter, P; Jakupec, MA; Jensen, F; Keppler, BK; Roller, A; Theiner, S; Varbanov, HP | 1 |
| Hassan, U; Mozayani, B; Wong, NA | 1 |
| Divsalar, A; Izadi, Z; Saboury, AA; Sawyer, L | 1 |
| Cao, W; Li, Y; Liu, L; Tian, L; Wei, Q | 1 |
| Blank, H; Bräse, S; Brenner, P; Crone, M; Esselen, M; Gehrke, H; Gerthsen, D; Marko, D; Muller, T; Pelka, J; Schneider, R; Send, W; Türk, M; Zibat, V | 1 |
| Bryce, NS; Hambley, TW; Whan, RM; Yamamoto, N; Zhang, JZ | 1 |
| Ekblad, L; Johnsson, A; Kjellström, J | 1 |
| Koyanagi, S; Maruyama, K; Matsunaga, N; Ohdo, S; Okazaki, F; Okazaki, H; Suzuki, R; Utoguchi, N | 1 |
| Engelmann, BJ; Farrell, NP; Kabolizadeh, P; Pullen, N; Ryan, JJ; Stewart, JK | 1 |
| Bryce, NS; Chen, CK; de Jonge, MD; Hambley, TW; Howard, DL; Lanzirotti, A; Paterson, D; Zhang, JZ | 1 |
| Böhm, U; Jaehde, U; Junker, A; Kretzschmar, A; Langenbahn, D; Pieck, AC; Tannapfel, A | 1 |
| Funakoshi, T; Kojima, S; Shimada, H; Takahashi, K | 1 |
| Allain, P; Buquet-Fagot, C; Cvitkovic, E; Djelloul, S; Gespach, C; Louvet, C; Mester, J; Raymond, E | 1 |
| Chaney, SG; Luo, FR; Wyrick, SD | 1 |
| Caserini, C; Colangelo, D; Farrell, N; Gatti, L; Leone, R; Perego, P; Spinelli, S; Supino, R; Zunino, F | 1 |
| Elliott, WL; Farrell, NP; Hoeschele, JD; Kraker, AJ; Sercel, AD; Showalter, HD | 1 |
| den Engelse, L; Los, G; McVie, JG; Pinedo, HM; Smals, OA; van der Vlist, M; van Vugt, MJ | 1 |
| Ewers, SB; Jönsson, L; Lamm, IL; Lindén, CJ; Samuelsson, L | 1 |
| Fram, RJ; Robichaud, N; Wilson, JM; Woda, BA | 1 |
1 review(s) available for platinum and Colonic Neoplasms
| Article | Year |
|---|---|
The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer.
Topics: Colonic Neoplasms; Colorectal Neoplasms; DNA Damage; Humans; Platinum; Poly(ADP-ribose) Polymerase Inhibitors | 2020 |
35 other study(ies) available for platinum and Colonic Neoplasms
| Article | Year |
|---|---|
Platinum-Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment.
Topics: Animals; Antineoplastic Agents; Colonic Neoplasms; Humans; Immunosuppressive Agents; Macrophages; Membrane Glycoproteins; Mice; Myeloid Cells; Platinum; Receptors, Immunologic; Tumor Microenvironment | 2023 |
Platinum(IV) combo prodrugs containing cyclohexane-1
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Diamines; Histone Deacetylases; Humans; Platinum; Prodrugs; Valproic Acid | 2023 |
Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Resistance, Neoplasm; Ferroptosis; Humans; Oxaliplatin; Platinum | 2024 |
Platinum-gold nanoraspberries as effective photosensitizer in anticancer photothermal therapy.
Topics: Cell Line, Tumor; Colonic Neoplasms; Gold; Humans; Hyperthermia, Induced; Metal Nanoparticles; Nanomedicine; Photosensitizing Agents; Phototherapy; Platinum | 2019 |
Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carbon-Sulfur Lyases; Cell Proliferation; Colonic Neoplasms; Fluorescence; Fluorouracil; Humans; Mice, Nude; Peritoneum; Platinum; Recombinant Proteins; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Fancy-Shaped Gold-Platinum Nanocauliflowers for Improved Proton Irradiation Effect on Colon Cancer Cells.
Topics: Cell Survival; Colonic Neoplasms; Gold; Green Chemistry Technology; HCT116 Cells; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Platinum; Proton Therapy; Protons; Radiation-Sensitizing Agents; Spectrometry, X-Ray Emission | 2020 |
Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells.
Topics: Cation Transport Proteins; Cell Survival; Cisplatin; Colonic Neoplasms; Copper; Copper Transporter 1; Dose-Response Relationship, Drug; Homeostasis; Humans; Platinum; Structure-Activity Relationship | 2017 |
Bio-synthesis of peppermint leaf extract polyphenols capped nano-platinum and their in-vitro cytotoxicity towards colon cancer cell lines (HCT 116).
Topics: Cell Line, Tumor; Colonic Neoplasms; Humans; Mentha piperita; Nanostructures; Platinum; Polyphenols | 2017 |
Black Pigment Gallstone Inspired Platinum-Chelated Bilirubin Nanoparticles for Combined Photoacoustic Imaging and Photothermal Therapy of Cancers.
Topics: Animals; Antineoplastic Agents; Bilirubin; Chelating Agents; Cisplatin; Colonic Neoplasms; HT29 Cells; Humans; Hyperthermia, Induced; Infrared Rays; Mice; Nanoparticles; Photoacoustic Techniques; Phototherapy; Platinum; Theranostic Nanomedicine | 2017 |
Fast High-Resolution Laser Ablation-Inductively Coupled Plasma Mass Spectrometry Imaging of the Distribution of Platinum-Based Anticancer Compounds in Multicellular Tumor Spheroids.
Topics: Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; HCT116 Cells; Humans; Oxaliplatin; Phosphorus; Platinum; Spheroids, Cellular | 2017 |
DN604: A platinum(II) drug candidate with classic SAR can induce apoptosis via suppressing CK2-mediated p-cdc25C subcellular localization in cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carboplatin; cdc25 Phosphatases; Cell Cycle Checkpoints; Cell Proliferation; Checkpoint Kinase 2; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Platinum; Stomach Neoplasms; Structure-Activity Relationship; Subcellular Fractions; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Palladium(ii) and platinum(ii) saccharinate complexes with bis(diphenylphosphino)methane/ethane: synthesis, S-phase arrest and ROS-mediated apoptosis in human colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Biological Transport; Chemistry Techniques, Synthetic; Colonic Neoplasms; DNA; DNA Breaks, Double-Stranded; Ethane; HCT116 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Membrane Potential, Mitochondrial; Methane; Molecular Docking Simulation; Nucleic Acid Conformation; Organoplatinum Compounds; Palladium; Platinum; Protein Conformation; Reactive Oxygen Species; S Phase Cell Cycle Checkpoints; Serum Albumin, Human | 2018 |
In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Coordination Complexes; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Kidney; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxaliplatin; Platinum; Titanium; Xenograft Model Antitumor Assays | 2018 |
Intelligent Hollow Pt-CuS Janus Architecture for Synergistic Catalysis-Enhanced Sonodynamic and Photothermal Cancer Therapy.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Copper; Humans; Hyperthermia, Induced; Mice; Nanoparticles; Platinum; Tumor Hypoxia; Ultrasonic Therapy | 2019 |
miR-211 facilitates platinum chemosensitivity by blocking the DNA damage response (DDR) in ovarian cancer.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Comet Assay; DNA Damage; Female; Humans; Immunohistochemistry; In Situ Hybridization; In Vitro Techniques; Mice; Mice, Nude; MicroRNAs; Ovarian Neoplasms; Phosphoric Diester Hydrolases; Platinum | 2019 |
Application of low-energy scanning transmission electron microscopy for the study of Pt-nanoparticle uptake in human colon carcinoma cells.
Topics: Colonic Neoplasms; HT29 Cells; Humans; Metal Nanoparticles; Microscopy, Electron, Scanning Transmission; Particle Size; Platinum | 2014 |
A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Physical; Colonic Neoplasms; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Hydrophobic and Hydrophilic Interactions; Leukemia L1210; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, SCID; Models, Molecular; Organoplatinum Compounds; Oxidation-Reduction; Platinum; Quantum Theory; Structure-Activity Relationship; Thermodynamics | 2014 |
Primary combined neuroendocrine carcinoma (small-cell type) and squamous cell carcinoma of the colon.
Topics: Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Neuroendocrine; Carcinoma, Squamous Cell; Colon; Colonic Neoplasms; Etoposide; Fatal Outcome; Humans; Male; Platinum; Point Mutation; Proto-Oncogene Proteins p21(ras); Tomography, X-Ray Computed | 2016 |
β-lactoglobulin-pectin Nanoparticle-based Oral Drug Delivery System for Potential Treatment of Colon Cancer.
Topics: Administration, Oral; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Humans; Hydrogen-Ion Concentration; Lactoglobulins; Microscopy, Electron, Scanning; Nanoparticles; Osmolar Concentration; Particle Size; Pectins; Platinum | 2016 |
Ultrasensitive sandwich-type electrochemical immunosensor based on trimetallic nanocomposite signal amplification strategy for the ultrasensitive detection of CEA.
Topics: Antibodies, Immobilized; beta-Cyclodextrins; Biomarkers, Tumor; Biosensing Techniques; Carcinoembryonic Antigen; Colonic Neoplasms; Electrochemical Techniques; Graphite; Humans; Hydrogen Peroxide; Metal Nanoparticles; Nanocomposites; Nickel; Oxidation-Reduction; Platinum; Silver | 2016 |
Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity.
Topics: Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Comet Assay; DNA Damage; DNA-Formamidopyrimidine Glycosylase; Glutathione; Humans; Metal Nanoparticles; Microscopy, Electron, Transmission; Particle Size; Platinum; Reactive Oxygen Species | 2009 |
Accumulation of an anthraquinone and its platinum complexes in cancer cell spheroids: the effect of charge on drug distribution in solid tumour models.
Topics: Anthraquinones; Cell Line, Tumor; Colonic Neoplasms; Humans; Microscopy, Confocal; Organoplatinum Compounds; Platinum; Spheroids, Cellular | 2009 |
Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Drug Resistance, Neoplasm; Gene Expression; Humans; Organoplatinum Compounds; Oxaliplatin; Platinum; RNA, Messenger; Toxicity Tests | 2010 |
Circadian rhythm of transferrin receptor 1 gene expression controlled by c-Myc in colon cancer-bearing mice.
Topics: Animals; Circadian Rhythm; Colonic Neoplasms; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, myc; Liposomes; Male; Mice; Mice, Inbred BALB C; Organoplatinum Compounds; Oxaliplatin; Platinum; Proto-Oncogene Proteins c-myc; Receptors, Transferrin; RNA, Messenger; Transferrin | 2010 |
Platinum anticancer agents and antidepressants: desipramine enhances platinum-based cytotoxicity in human colon cancer cells.
Topics: Antidepressive Agents; Antineoplastic Agents; Apoptosis; Cell Proliferation; Colonic Neoplasms; Desipramine; DNA; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Organoplatinum Compounds; Platinum; Serum Albumin; Structure-Activity Relationship; Tumor Cells, Cultured | 2012 |
Getting to the core of platinum drug bio-distributions: the penetration of anti-cancer platinum complexes into spheroid tumour models.
Topics: Anthraquinones; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Electricity; Female; Formaldehyde; Histocytological Preparation Techniques; Humans; Intracellular Space; Necrosis; Ovarian Neoplasms; Platinum; Spheroids, Cellular | 2012 |
[Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
Topics: Antineoplastic Agents; Colonic Neoplasms; Humans; Liver Neoplasms; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Platinum | 2004 |
Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
Topics: Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Carcinoma; Chelating Agents; Cisplatin; Colonic Neoplasms; Diarrhea; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Platinum; Thiocarbamates; Tissue Distribution | 1993 |
Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cell Survival; Colonic Neoplasms; DNA, Neoplasm; Enzyme Inhibitors; Female; Fluorouracil; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Platinum; Thymidylate Synthase; Tumor Cells, Cultured | 1997 |
Cytotoxicity, cellular uptake, and cellular biotransformations of oxaliplatin in human colon carcinoma cells.
Topics: Antineoplastic Agents; Biotransformation; Carcinoma; Colonic Neoplasms; DNA Adducts; Humans; Organoplatinum Compounds; Oxaliplatin; Platinum; Tumor Cells, Cultured | 1998 |
The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells.
Topics: Adaptor Proteins, Signal Transducing; Adenosine Triphosphatases; Antineoplastic Agents; Base Pair Mismatch; Bone Neoplasms; Carcinoma; Carrier Proteins; Cisplatin; Colonic Neoplasms; Cross-Linking Reagents; DNA Polymerase beta; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; DNA, Neoplasm; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Mismatch Repair Endonuclease PMS2; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Organoplatinum Compounds; Osteosarcoma; Platinum; Proteins; Proto-Oncogene Proteins; Tumor Cells, Cultured | 1999 |
Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Colonic Neoplasms; Diamines; Drug Resistance; Humans; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Malonates; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Nude; Molecular Structure; Platinum; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
A rationale for carboplatin treatment and abdominal hyperthermia in cancers restricted to the peritoneal cavity.
Topics: Adenocarcinoma; Animals; Body Temperature; Carboplatin; Colonic Neoplasms; Combined Modality Therapy; Hyperthermia, Induced; Injections, Intraperitoneal; Injections, Intravenous; Male; Peritoneal Neoplasms; Platinum; Rats; Tissue Distribution | 1992 |
Electrolysis with different electrode materials and combined with irradiation for treatment of experimental rat tumors.
Topics: Animals; Colonic Neoplasms; Combined Modality Therapy; Copper; Electrodes, Implanted; Electrolysis; Mesothelioma; Neoplasm Transplantation; Neoplasms, Experimental; Platinum; Rats; Rats, Inbred WF; Rats, Nude; Rhodium; Zinc | 1991 |
Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.
Topics: Antineoplastic Agents; Cell Cycle; Cisplatin; Colonic Neoplasms; DNA Damage; DNA, Neoplasm; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Glutathione; Humans; Kinetics; Platinum; Sulfhydryl Compounds; Tumor Cells, Cultured | 1990 |